Unfortunately, there is no cure for gastroparesis, and it requires lifelong medical management. So, it is important to consult with a healthcare provider and understand the risks before using GLP-1 agonists to treat obesity, diabetes, and weight gain
Many patients start feeling better before we've even finished the infusion
Diabetes Care 40, 821831
The India Semaglutide market is estimated to be valued at USD 1.39 Bn in 2026 and is expected to reach USD 3.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2026 to 2032
Sources Diab, H., Fuquay, T., Datta, P., Bickel, U., Thompson, J., & Krutsch, K
Any research behind Akkermansia and inulin was conducted on those ingredients - often at doses, delivery methods, and in study populations that may not match what's actually in a Hello100 capsule